- Home
- MYGN vs TOWN Comparison
MYGN vs TOWN Comparison
Compare MYGN & TOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- TOWN
- Stock Information
- Founded
- MYGN 1991
- TOWN 1998
- Country
- MYGN United States
- TOWN United States
- Employees
- MYGN N/A
- TOWN N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TOWN Major Banks
- Sector
- MYGN Health Care
- TOWN Finance
- Exchange
- MYGN Nasdaq
- TOWN Nasdaq
- Market Cap
- MYGN 2.2B
- TOWN 2.5B
- IPO Year
- MYGN 1995
- TOWN 1999
- Fundamental
- Price
- MYGN $26.43
- TOWN $32.47
- Analyst Decision
- MYGN Buy
- TOWN Buy
- Analyst Count
- MYGN 12
- TOWN 2
- Target Price
- MYGN $28.18
- TOWN $36.00
- AVG Volume (30 Days)
- MYGN 651.3K
- TOWN 228.8K
- Earning Date
- MYGN 11-04-2024
- TOWN 10-24-2024
- Dividend Yield
- MYGN N/A
- TOWN 3.10%
- EPS Growth
- MYGN N/A
- TOWN N/A
- EPS
- MYGN N/A
- TOWN 2.02
- Revenue
- MYGN $802,200,000.00
- TOWN $668,083,000.00
- Revenue This Year
- MYGN $13.84
- TOWN N/A
- Revenue Next Year
- MYGN $9.57
- TOWN $10.45
- P/E Ratio
- MYGN N/A
- TOWN $15.99
- Revenue Growth
- MYGN 14.78
- TOWN N/A
- 52 Week Low
- MYGN $13.82
- TOWN $21.63
- 52 Week High
- MYGN $29.30
- TOWN $35.10
- Technical
- Relative Strength Index (RSI)
- MYGN 44.56
- TOWN 43.03
- Support Level
- MYGN $25.90
- TOWN $31.88
- Resistance Level
- MYGN $27.55
- TOWN $33.09
- Average True Range (ATR)
- MYGN 0.88
- TOWN 0.79
- MACD
- MYGN -0.07
- TOWN -0.23
- Stochastic Oscillator
- MYGN 15.59
- TOWN 18.32
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About TOWN TowneBank
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and Insurance Segment provides provide a wide array of insurance products, including property, casualty, life, and health insurance.